Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07066813 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later May 31, 2026 → Oct 31, 2026
See other at-risk trials from Central South University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from May 31, 2026 to Oct 31, 2026
    • Study completion pushed from Jul 1, 2026 to Nov 1, 2026
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Dec 31, 2025 to May 31, 2026v3
  4. Trial status: Active, Not Recruiting to Recruiting
    • Secondary endpoints revised (5)
    • Site details revised
    • Study title shortened, about 1 word
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to determine the most accurate tumor size measurement method for T-staging and prognostic assessment in lung cancer with cystic airspaces (LCCA). The main questions it aims to answer are: * What is the optimal T-staging approach for accurately classifying lung cancer with cystic airspaces （LCCA) and predicting patient outcomes? * How do imaging features of cystic lesions correlate with their pathological characteristics? * What is the relationship between imaging features of cystic airspace-associated lesions and patient prognosis? * Can optimizing the T-staging method improve clinical decision-making in patients with LCCA?
Trial Details
NCT Number NCT07066813
Lead Sponsor Central South University
Conditions
(from sponsor)		 Lung Cancer Associated With Cystic Airspaces
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov